Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren E Rose

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|August 8, 2012
Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activityWarren E Rose, Lucas T Schulz, David Andes, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2021
Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant Staphylococcus aureus: <i>In Vitro</i>, <i>Ex Vivo</i>, and <i>In Vivo</i> MetricsNagendra N Mishra, Cassandra Lew, Wessam Abdelhady, et al.
The Journal of Infectious Diseases|March 30, 2013
Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureusCeline Vidaillac, Susana Gardete, Ryan Tewhey, et al.
The Annals of Pharmacotherapy|May 18, 2017
Fosfomycin tromethamine for the Treatment of Cystitis in Abdominal Solid Organ Transplant Recipients With Renal DysfunctionLuiza Kerstenetzky, Margaret R Jorgenson, Jillian L Descourouez, et al.
Clinical Therapeutics|January 4, 2011
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort studyChristopher W Crank, Marc H Scheetz, Benjamin Brielmaier, et al.
Antimicrobial Agents and Chemotherapy|April 3, 2019
Geographic Mapping of Escherichia coli Susceptibility To Develop a Novel Clinical Decision Support ToolLaurel Legenza, Susanne Barnett, James P Lacy, et al.
The Journal of Biological Chemistry|August 20, 2017
A screen for kinase inhibitors identifies antimicrobial imidazopyridine aminofurazans as specific inhibitors of the <i>Listeria monocytogenes</i> PASTA kinase PrkAAdam J Schaenzer, Nathan Wlodarchak, David H Drewry, et al.
The Journal of Infectious Diseases|September 12, 2012
Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremiaWarren E Rose, Jens C Eickhoff, Sanjay K Shukla, et al.
Antimicrobial Agents and Chemotherapy|October 23, 2013
Daptomycin dosing based on ideal body weight versus actual body weight: comparison of clinical outcomesJennifer K Ng, Lucas T Schulz, Warren E Rose, et al.
Plos Pathogens|October 8, 2021
PASTA kinase-dependent control of peptidoglycan synthesis via ReoM is required for cell wall stress responses, cytosolic survival, and virulence in Listeria monocytogenesJessica L Kelliher, Caroline M Grunenwald, Rhiannon R Abrahams, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|August 8, 2012
Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activityWarren E Rose, Lucas T Schulz, David Andes, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2021
Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant Staphylococcus aureus: <i>In Vitro</i>, <i>Ex Vivo</i>, and <i>In Vivo</i> MetricsNagendra N Mishra, Cassandra Lew, Wessam Abdelhady, et al.
The Journal of Infectious Diseases|March 30, 2013
Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureusCeline Vidaillac, Susana Gardete, Ryan Tewhey, et al.
The Annals of Pharmacotherapy|May 18, 2017
Fosfomycin tromethamine for the Treatment of Cystitis in Abdominal Solid Organ Transplant Recipients With Renal DysfunctionLuiza Kerstenetzky, Margaret R Jorgenson, Jillian L Descourouez, et al.
Clinical Therapeutics|January 4, 2011
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort studyChristopher W Crank, Marc H Scheetz, Benjamin Brielmaier, et al.
Antimicrobial Agents and Chemotherapy|April 3, 2019
Geographic Mapping of Escherichia coli Susceptibility To Develop a Novel Clinical Decision Support ToolLaurel Legenza, Susanne Barnett, James P Lacy, et al.
The Journal of Biological Chemistry|August 20, 2017
A screen for kinase inhibitors identifies antimicrobial imidazopyridine aminofurazans as specific inhibitors of the <i>Listeria monocytogenes</i> PASTA kinase PrkAAdam J Schaenzer, Nathan Wlodarchak, David H Drewry, et al.
The Journal of Infectious Diseases|September 12, 2012
Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremiaWarren E Rose, Jens C Eickhoff, Sanjay K Shukla, et al.
Antimicrobial Agents and Chemotherapy|October 23, 2013
Daptomycin dosing based on ideal body weight versus actual body weight: comparison of clinical outcomesJennifer K Ng, Lucas T Schulz, Warren E Rose, et al.
Plos Pathogens|October 8, 2021
PASTA kinase-dependent control of peptidoglycan synthesis via ReoM is required for cell wall stress responses, cytosolic survival, and virulence in Listeria monocytogenesJessica L Kelliher, Caroline M Grunenwald, Rhiannon R Abrahams, et al.
Pageof 11